Humana Inc HUM shares are trading lower after the company reaffirmed its FY21 EPS guidance below analyst estimates.
In addition, per a Thursday Form 8-K, Humana continues to expect group Medicare Advantage membership to be generally flat for 2022, as the company does not anticipate any large accounts will be gained or lost as it continues to maintain pricing discipline in a highly competitive market.
See Also: Why Bed Bath & Beyond Shares Are Trading Higher Today
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid and the military's Tricare program.
Humana has a 52-week high of $475.44 and a 52-week low of $370.22.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.